Jump to content

Homarylamine

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Tekmeme (talk | contribs) at 17:47, 22 January 2018 (Added Norlobivine as synonym in Drugbox). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Homarylamine
Clinical data
Other names1,3-benzodioxolyl-N-methyl-5-ethanamine;
3,4-methylenedioxy-N-methyl-2-phenylethylamine;
Norlobivine
Routes of
administration
Various
Identifiers
  • 2-(1,3-Benzodioxol-5-yl)-N-methylethanamine
CAS Number
PubChem CID
ChemSpider
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC10H13NO2
Molar mass179.21572 g/mol g·mol−1
3D model (JSmol)
  • CNCCC1=CC2=C(C=C1)OCO2
  • InChI=1S/C10H13NO2/c1-11-5-4-8-2-3-9-10(6-8)13-7-12-9/h2-3,6,11H,4-5,7H2,1H3
  • Key:OPJOMVMFYOUDPK-UHFFFAOYSA-N
  (verify)

Homarylamine (INN;[1] also known as 3,4-methylenedioxy-N-methylphenethylamine or MDMPEA) is a substituted phenethylamine. It is the N-methylated analog of MDPEA.

Homoarylamine is known to have been patented for use as an antitussive agent.[2]

Derivatives

  1. Cyclization of Homoarylamine with formaldehyde gives Hydrastinine.
  2. Hydrastine

References

  1. ^ "International Non-Proprietary Names for Pharmaceutical Preparations" (PDF). Chronicle of the World Health Organization. 12 (3). 1958.
  2. ^ U.S. patent 2,820,739